Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

#How Has the Oncology Molecular Diagnostics Market Growth Performance Trended Historically, And What Lies Ahead?

The market size of oncology molecular diagnostics has witnessed rapid expansion in recent years, expected to escalate from $4.84 billion in 2024 to $5.65 billion in 2025, with a compound annual growth rate (CAGR) of 16.7%. This significant growth in the historic period can be credited to the entrance of preliminary tests, advancements in genomic profiling, the introduction of next-generation sequencing (NGS), identification of biomarkers at early stages, and the development of targeted therapies.

What Is the Forecast for the Oncology Molecular Diagnostics Market Size Through 2029?

In the upcoming years, the oncology molecular diagnostics market is anticipated to witness a swift expansion. The market is projected to soar to $8.99 billion by 2029, with a compound annual growth rate (CAGR) of 12.3%. This growth during the anticipated period can be credited to the development in liquid biopsy, the emergence of companion diagnostics, the incorporation of artificial intelligence (AI), the broadening of ngs applications, and the ongoing evolution in biomarker identification. Key trends anticipated during this forecast period encompass global accessibility, biomarker detection and validation, refinement in regulatory frameworks, enhancements in technological platforms, and patient-focused care models.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=3457&type=smp

What are the Key Market Players in Oncology Molecular Diagnostics Market and How They’re Evolving?

Major companies operating in the oncology molecular diagnostics market include F. Hoffmann-La Roche AG, Bayer AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthcare AG, Becton Dickinson and Company, Agilent Technologies Inc., HTG Molecular Diagnostics Inc., Hologic Inc., Illumina Inc., bioMérieux SA, Beckman Coulter Inc., Sysmex Corporation, Bio-Rad Laboratories Inc., Qiagen N.V., Exact Sciences Corp., Bio-Techne Corporation, OPKO Health Inc., Myriad Genetics Inc., Guardant Health AMEA, Veracyte Inc., Adaptive Biotechnologies Corp., Foundation Medicine Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Genomic Health Inc.

What Are the Primary Growth Drivers in the Oncology Molecular Diagnostics Market?

The global surge in cancer cases is expected to stimulate the expansion of the oncology molecular diagnostics market. As an illustration, data from the American Cancer Society reveals that approximately 1.9 million new instances of cancer and 609,360 cancer-related fatalities are projected for 2022 in the U.S. Similar estimations are made for 2023, predicting around 1,958,310 fresh cancer diagnoses and 609,820 cancer-related deaths. The four most prevalent cancer types globally include lung, prostate, bowel, and female breast cancer. As a result, the worldwide increase in the prevalence of cancer is forecasted to drive the demand for the oncology molecular diagnostics market in the forthcoming years.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=3457&type=smp

What Are the Leading Segments in the Global Oncology Molecular Diagnostics Industry?

The oncology molecular diagnostics market covered in this report is segmented –

1) By Product: Instruments, Reagents, Other Products

2) By Technology: Polymerase Chain Reaction (PCR), In-situ Hybridization (ISH), Isothermic Nucleic Acid Amplification Technology (INNAT), Chips & Microarrays, Sequencing, Mass Spectroscopy, Transcription Mediated Amplification (TMA), Other Technologies

3) By End User: Hospitals, Diagnostic Centers, Academic & Research Institutes, Other End Users

Subsegments:

1) By Instruments: PCR (Polymerase Chain Reaction) Machines, Sequencers, Microarray Platforms, Fluorescence In Situ Hybridization (FISH) Instruments

2) By Reagents: DNA And RNA Extraction Kits, PCR Reagents And Kits, NGS Library Preparation Kits, Diagnostic Assay Reagents

3) By Other Products: Software For Data Analysis And Interpretation, Quality Control And Calibration Products, Consumables, For Molecular Testing, Biomarkers For Oncology Testing

What Are the Key Market Trends in the Oncology Molecular Diagnostics Industry?

A key trend in the oncology molecular diagnostics market is the notable advancement in genomics technology. The progress in cancer genome sequencing technology, computational analysis, tumor models, and the inception of contemporary cancer research methods enables early detection of cancer and identification of mutations. For example, in May 2024, a state-of-the-art facility nicknamed OncoHelix-CoLab, was introduced at Burjeel Medical City in the UAE. This Canada-based precision oncology specialist facility emphasizes genomic and immunologic profiling for cancer treatment, advanced molecular diagnostics, and immune profile testing. This collaboration between Burjeel Holdings and OncoHelix aims to enhance the diagnostic precision and efficiency by conducting intricate tests locally, cancelling out the need to send samples overseas. In connection to their services, they have an offering of sophisticated tests for a variety of cancers including prostate cancer, following alliances like the one with Nanostics for the ClarityDX Prostate test.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/oncology-molecular-diagnostics-global-market-report

What Is the Regional Outlook for the Oncology Molecular Diagnostics Market?

The countries covered in the oncology molecular diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=3457

This Report Delivers Insight On:

1. How big is the oncology molecular diagnostics market, and how is it changing globally?

2. Who are the major companies in the oncology molecular diagnostics market, and how are they performing?

3. What are the key opportunities and risks in the oncology molecular diagnostics market right now?

4. Which products or customer segments are growing the most in the oncology molecular diagnostics market?

5. What factors are helping or slowing down the growth of the oncology molecular diagnostics market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model